Liver fibrosis progression in patients with chronic hepatitis B: a prospective study with paired transient elastography
VWS Wong, HLY Chan, GLH Wong
Department of Medicine and Therapeutics, The Chinese University of
Hong Kong
1. Liver fibrosis progression is uncommon in
chronic hepatitis B patients with normal liver
function tests.
2. In patients with active disease, antiviral therapy can effectively prevent fibrosis progression and even result in fibrosis regression.
3. Metabolic syndrome approximately doubles the risk of fibrosis progression.
4. Clinicians should monitor and manage metabolic disease in patients with chronic hepatitis B.
2. In patients with active disease, antiviral therapy can effectively prevent fibrosis progression and even result in fibrosis regression.
3. Metabolic syndrome approximately doubles the risk of fibrosis progression.
4. Clinicians should monitor and manage metabolic disease in patients with chronic hepatitis B.